Galapagos Reports the First Patient Dosing of GLPG3667 in the P-II Study (GALARISSO) for the Treatment of Dermatomyositis
May 24, 2023
Galapagos Reports Initiation of P-III Trial (OLINGUITO) for Filgotinib to Treat Active Axial Spondyloarthritis
April 28, 2023
Galapagos Reports P-III Trial (DIVERSITY) Results of Filgotinib for the Treatment of Crohn’s Disease
February 9, 2023
Galapagos to Acquire CellPoint and AboundBio to Advance Cell Therapies for the Treatment of Advanced Cancer
June 22, 2022
Galapagos Reports Completion of Patient Enrollment in P-II MANGROVE Trial of GLPG2737 for the Treatment of Polycystic Kidney Disea...
November 24, 2021
PharmaShots Weekly Snapshots (July 12 - 16, 2021)
July 16, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.